FRANKLIN LAKES, N.J., May 12, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. launch of its new, fully ...

FRANKLIN LAKES, N.J., Dec. 17, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to ...

The BD COR MX/PX System integrates and automates the complete molecular laboratory workflow, from sample processing to diagnostic test result for large, high-throughput labs. – BD Becton, Dickinson ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the launch of BD COR System, a new and fully-automated high-throughput diagnostic system utilizing robotics and sample ...

They say good things happen in threes, and BD seems to be hoping that adage rings true for its Cor molecular diagnostic platform. Two years after the automated lab-testing system made its European ...

As the science and technology behind genomic sequencing progresses, high-throughput molecular testing has increasingly become a crucial tool in identifying diseases in their earliest stages. Despite ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently introduced its new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States. With ...

Franklin Lakes-based BD (Becton, Dickinson and Co.) on Aug. 25 announced the launch of a new, fully automated high-throughput diagnostic system for U.S. labs Using robotics and sample management ...